178 related articles for article (PubMed ID: 9924927)
1. Leukemic pleural effusion in B-cell prolymphocytic leukemia.
Andrieu V; Encaoua R; Carbon C; Couvelard A; Grange MJ
Hematol Cell Ther; 1998 Dec; 40(6):275-8. PubMed ID: 9924927
[TBL] [Abstract][Full Text] [Related]
2. Successful treatment of B-cell prolymphocytic leukemia with monoclonal anti-CD20 antibody.
Mourad YA; Taher A; Chehal A; Shamseddine A
Ann Hematol; 2004 May; 83(5):319-21. PubMed ID: 15060751
[TBL] [Abstract][Full Text] [Related]
3. [Successful treatment by ranimustine (MCNU) of a patient with B-cell prolymphocytic leukemia (B-PLL)].
Wake A; Yamasaki Y; Ogawa R; Mori N; Nagata K; Nakata K; Misago M; Izumi Y; Fujita K; Oda S
Rinsho Ketsueki; 1993 Nov; 34(11):1464-9. PubMed ID: 8254909
[TBL] [Abstract][Full Text] [Related]
4. CD3-negative, CD20-positive T-cell prolymphocytic leukemia: case report and review of the literature.
Tamayose K; Sato N; Ando J; Sugimoto K; Oshimi K
Am J Hematol; 2002 Dec; 71(4):331-5. PubMed ID: 12447967
[TBL] [Abstract][Full Text] [Related]
5. Production of vascular endothelial growth factor in T-cell prolymphocytic leukemia.
Ogasawara T; Narita C; Kawauchi K
Leuk Res; 2007 Mar; 31(3):403-6. PubMed ID: 16620970
[TBL] [Abstract][Full Text] [Related]
6. B-Prolymphocytic leukemia: a case study.
Roberts JC; Roberts GH
Clin Lab Sci; 2001; 14(4):233-7. PubMed ID: 11760820
[TBL] [Abstract][Full Text] [Related]
7. Acute tumor lysis syndrome complicating fludarabine treatment of prolymphocytic leukemia.
Cannon LM; Spilove L; Rhodes R; Garfinkel H; Pezzimenti J
Conn Med; 1993 Oct; 57(10):651-4. PubMed ID: 8275684
[TBL] [Abstract][Full Text] [Related]
8. [Remission in T-cell prolymphocytic leukemia during the FMC treatment course].
Valiev TT; Vinogradova IuE; Chernova NG; Mar'in DS; Volkova IaK; Petrova VI; Bulanov AIu; Kalinin NN; Semenova EA; Gretsov EM; Kravchenko SK; Kremenetskaia AM; Vorob'ev AI
Ter Arkh; 2006; 78(7):87-90. PubMed ID: 16944758
[No Abstract] [Full Text] [Related]
9. Current treatment options in prolymphocytic leukemia.
Robak T; Robak P
Med Sci Monit; 2007 Apr; 13(4):RA69-80. PubMed ID: 17392661
[TBL] [Abstract][Full Text] [Related]
10. [Leukemic B-cell colony formation in patients with B-cell prolymphocytic leukemia].
Ishiyama T; Akimoto Y; Ueno H; Yajima K; Tomoyasu S; Tsuruoka N; Wakabayashi Y
Rinsho Ketsueki; 1993 Mar; 34(3):301-6. PubMed ID: 8479081
[TBL] [Abstract][Full Text] [Related]
11. Phenotypic changes of leukemic cells in a patient with prolympho-plasmacytic leukaemia after treatment with fludarabine.
Loria MP; Dell'Osso A; Grande M; Dambra P; D'Oronzio L; Crollo R; Lasaracina E; Lucivero G
Eur J Histochem; 1997; 41 Suppl 2():29-30. PubMed ID: 9859769
[No Abstract] [Full Text] [Related]
12. Efficacy of fludarabine, a new adenine nucleoside analogue, in patients with prolymphocytic leukemia and the prolymphocytoid variant of chronic lymphocytic leukemia.
Kantarjian HM; Childs C; O'Brien S; Huh Y; Beran M; Schachner J; Koller C; Keating MJ
Am J Med; 1991 Feb; 90(2):223-8. PubMed ID: 1996592
[TBL] [Abstract][Full Text] [Related]
13. [The prolymphocytic-lymphocytic leukemization of B-cell lymphosarcomas].
Osmanov DSh; Kruglova GV; Frenkel' MA; Tupitsin NN; Probatova NA; Kondrat'eva TT; Sholokhova EN; Finogenova IA; Dvoretskiĭ VV
Ter Arkh; 1996; 68(7):42-8. PubMed ID: 8928071
[TBL] [Abstract][Full Text] [Related]
14. Prolymphocytic transformation of B-chronic lymphocytic leukemia presenting as malignant ascites and pleural effusion.
Shimoni A; Shvidel L; Shtalrid M; Klepfish A; Berrebi A
Am J Hematol; 1998 Dec; 59(4):316-8. PubMed ID: 9840914
[No Abstract] [Full Text] [Related]
15. Richter's syndrome in a patient with B prolymphocytic leukemia.
Grange MJ; Andrieu V; Chemlal K
Haematologica; 1999 May; 84(5):461-641. PubMed ID: 10329926
[No Abstract] [Full Text] [Related]
16. Skin and gingival lesions in a young woman with B-prolymphocytic leukemia (B-PLL).
Panteli K; Bai M; Basioukas K; Vartholomatos G; Zioga K; Bourantas KL
J Exp Clin Cancer Res; 2001 Sep; 20(3):447-9. PubMed ID: 11718228
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of fludarabine in end-stage prolymphocytic leukemia.
Doorduijn JK; Michiels JJ
Leukemia; 1994 Aug; 8(8):1439. PubMed ID: 8057685
[No Abstract] [Full Text] [Related]
18. Development of malignant mesothelioma during treatment for prolymphocytic leukemia: is asbestos or simian virus 40 a link?
Tanvetyanon T; Elmishad AG; Carbone M
Anticancer Res; 2005; 25(1B):429-33. PubMed ID: 15816607
[TBL] [Abstract][Full Text] [Related]
19. Sustained response of refractory prolymphocytic leukemia to fludarabine.
Sporn JR
Acta Haematol; 1991; 85(4):209-11. PubMed ID: 1853684
[TBL] [Abstract][Full Text] [Related]
20. Clinical overview of pentostatin (Nipent) use in lymphoid malignancies.
Dearden CE; Matutes E; Catovsky D
Semin Oncol; 2000 Apr; 27(2 Suppl 5):22-6. PubMed ID: 10877047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
